(1) In the administration, distribution, storage, prescribing, and dispensing of controlled substances, APRNs shall comply with all applicable requirements in the Code of Federal Regulations (CFR), Title 21, and state law, including but not limited to, ORS Chapter 430 (Mental Health) and 475 and OAR chapter 415 and 855. Oregon Administrative Rules Division 80, Schedule of Controlled Substances. Refreshed: 2021-06-08 Which drugs does the Oregon PDMP monitor? The Oregon PDMP collects data on Schedules II, III and IV controlled substances and gabapentin. Beginning Jan 2025, the PDMP will begin collecting schedule V drugs and veterinarian prescribed controlled substances. The DEA allows Electronic Prescribing of Controlled Substances. 1 However, prescribers are not required to transmit controlled substances electronically, and pharmacies are not required to accept electronic prescriptions for controlled substances. Paper prescriptions for schedule II, III, IV, and V controlled substances are still permissible. Gabapentin isn’t a narcotic or federally controlled substance, but it is regulated and recognized as a controlled substance in certain states. Gabapentin is approved by the Food and Gabapentin isn’t considered a controlled substance by the federal government. But several states have passed their own laws limiting the prescribing and sale of it. Eight states have made gabapentin a schedule V controlled substance. that are classified in schedules II through IV under the federal Controlled Substances Act, 21 U.S.C. 811 and 812, as modified by the board by rule under ORS 475.035; (B) Prescribed gabapentin and naloxone dispensed by pharmacies; and Oregon Revised Statutes Title 37, Alcoholic Liquors; Controlled Substances; Drugs; Chapter 475, Controlled Substances; Illegal Drug Cleanup; Miscellaneous. Refreshed: 2023-06-16 Gabapentin is not currently listed as a controlled substance under the Controlled Substances Act of 1970. 11 Several state boards of pharmacy, as outlined in Supplemental Table 2 and Figure 1, have independently reclassified gabapentin under state pharmacy rules as a Schedule V drug. Other states have required gabapentin use to be monitored The PDMP collects data on Federally Scheduled II, III, and IV controlled substances, State Scheduled drugs including pseudoephedrine, state drugs of interest gabapentin and naloxone. The Oregon PDMP maintains this data for 3 years from pharmacy fill date. Discover the current status of gabapentin scheduling as a controlled substance across the US and the PDMP requirements for each state. Valuable insights for healthcare providers. Oregon has strict guidelines for prescribing controlled substances to ensure patient safety and prevent misuse. These regulations help healthcare providers balance effective pain management with preventing drug abuse and diversion. Gabapentin’s unscheduled status reflects its lower potential for abuse or dependency compared to controlled substances. However, the FDA monitors gabapentin for potential misuse, particularly when combined with other central nervous system depressants. This oversight aims to balance its therapeutic benefits against abuse risks. Regional Variation Gabapentin (Neurontin) is not a narcotic or federally controlled substance by the DEA as of November 2022, but it is classified as a Schedule V controlled substance in certain states. Twelve states have not classified gabapentin as a controlled substance, but require gabapentin dispensing must be reported to their PMP (including CT, DC, IN, KS, MA, MN, NE, NJ, OH, OR, UT, and WY). single substance pharmaceutical exposures (i.e., the number of human exposure cases that identified only one substance), gabapentin was identified as a single substance in 6,955 cases in 2022. With respect to medical outcomes associated with gabapentin calls to poison control centers in 2022, gabapentin was associated with 6 deaths, 164 855-080-0020 Schedules Pursuant to ORS 475.005(6) those drugs and their immediate precursors classified in Schedules I through V under the Federal Controlled Substances Act, 21 USC 811 (03/23/2024), 21 USC 812 (03/23/2024) and as amended by the board pursuant to ORS 475.035 are the controlled substances for purposes of regulation and control under the Act. The following is a list of resources to provide the most up-to-date information on laws and rules governing the practice of pharmacy and controlled substances: Oregon Revised Statutes - Chapter 689 Oregon Revised Statutes - Chapter 475 The Drug Enforcement Administration (DEA) advises veterinarians to not provide their DEA license number for non-controlled substance prescriptions. Pharmacies that dispense from a veterinarian’s prescription should instead request the veterinarian’s license number. Pharmacies submit prescription data to the PDMP system for all Schedules II, III and IV controlled substances, gabapentin, and naloxone dispensed from Oregon pharmacies and to Oregon residents from non-resident pharmacies.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |